# Cell Thalamus Phase 0 - Complete Viability Table

**Design ID:** `70de9fd2-425e-45a5-a02a-5cc97dd96ab7`
**Date:** December 16, 2025
**Total Wells:** 2,304 (10 compounds Ã— 4 doses Ã— 2 cell lines Ã— 2 timepoints Ã— 2 days Ã— 2 operators Ã— 3 replicates)

---

## Complete Dataset

| Compound | Dose (ÂµM) | Cell Line | Timepoint | N | Avg LDH | Viability % |
|----------|-----------|-----------|-----------|---|---------|-------------|
| **CCCP** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| CCCP | 0.5 | A549 | 12h | 12 | 235 | **99.7** |
| CCCP | 5.0 | A549 | 12h | 12 | 15,173 | **79.3** |
| CCCP | 50.0 | A549 | 12h | 12 | 47,123 | **35.7** |
| CCCP | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| CCCP | 0.5 | A549 | 48h | 12 | 240 | **99.7** |
| CCCP | 5.0 | A549 | 48h | 12 | 17,100 | **76.8** |
| CCCP | 50.0 | A549 | 48h | 12 | 47,027 | **36.2** |
| CCCP | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| CCCP | 0.5 | HepG2 | 12h | 12 | 981 | **98.4** |
| CCCP | 5.0 | HepG2 | 12h | 12 | 31,532 | **48.8** |
| CCCP | 50.0 | HepG2 | 12h | 12 | 43,965 | **28.6** |
| CCCP | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| CCCP | 0.5 | HepG2 | 48h | 12 | 1,007 | **98.6** |
| CCCP | 5.0 | HepG2 | 48h | 12 | 30,846 | **56.5** |
| CCCP | 50.0 | HepG2 | 48h | 12 | 49,833 | **29.7** |
| **H2O2** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| H2O2 | 10.0 | A549 | 12h | 12 | 896 | **98.8** |
| H2O2 | 100.0 | A549 | 12h | 12 | 30,104 | **58.9** |
| H2O2 | 1000.0 | A549 | 12h | 12 | 45,622 | **37.7** |
| H2O2 | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| H2O2 | 10.0 | A549 | 48h | 12 | 907 | **98.8** |
| H2O2 | 100.0 | A549 | 48h | 12 | 34,685 | **52.9** |
| H2O2 | 1000.0 | A549 | 48h | 12 | 43,199 | **41.4** |
| H2O2 | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| H2O2 | 10.0 | HepG2 | 12h | 12 | 223 | **99.6** |
| H2O2 | 100.0 | HepG2 | 12h | 12 | 14,706 | **76.1** |
| H2O2 | 1000.0 | HepG2 | 12h | 12 | 46,387 | **24.6** |
| H2O2 | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| H2O2 | 10.0 | HepG2 | 48h | 12 | 195 | **99.7** |
| H2O2 | 100.0 | HepG2 | 48h | 12 | 14,729 | **79.2** |
| H2O2 | 1000.0 | HepG2 | 48h | 12 | 46,808 | **34.0** |
| **MG132** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| MG132 | 0.1 | A549 | 12h | 12 | 249 | **99.7** |
| MG132 | 1.0 | A549 | 12h | 12 | 13,944 | **81.0** |
| MG132 | 10.0 | A549 | 12h | 12 | 42,750 | **41.6** |
| MG132 | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| MG132 | 0.1 | A549 | 48h | 12 | 228 | **99.7** |
| MG132 | 1.0 | A549 | 48h | 12 | 15,497 | **79.0** |
| MG132 | 10.0 | A549 | 48h | 12 | 45,083 | **38.8** |
| MG132 | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| MG132 | 0.1 | HepG2 | 12h | 12 | 900 | **98.5** |
| MG132 | 1.0 | HepG2 | 12h | 12 | 27,953 | **54.6** |
| MG132 | 10.0 | HepG2 | 12h | 12 | 44,025 | **28.5** |
| MG132 | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| MG132 | 0.1 | HepG2 | 48h | 12 | 926 | **98.7** |
| MG132 | 1.0 | HepG2 | 48h | 12 | 28,915 | **59.2** |
| MG132 | 10.0 | HepG2 | 48h | 12 | 45,994 | **35.1** |
| **etoposide** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| etoposide | 1.0 | A549 | 12h | 12 | 988 | **98.7** |
| etoposide | 10.0 | A549 | 12h | 12 | 30,521 | **58.3** |
| etoposide | 100.0 | A549 | 12h | 12 | 44,887 | **38.7** |
| etoposide | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| etoposide | 1.0 | A549 | 48h | 12 | 995 | **98.6** |
| etoposide | 10.0 | A549 | 48h | 12 | 31,965 | **56.6** |
| etoposide | 100.0 | A549 | 48h | 12 | 50,263 | **31.8** |
| etoposide | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| etoposide | 1.0 | HepG2 | 12h | 12 | 298 | **99.5** |
| etoposide | 10.0 | HepG2 | 12h | 12 | 16,615 | **73.0** |
| etoposide | 100.0 | HepG2 | 12h | 12 | 42,568 | **30.8** |
| etoposide | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| etoposide | 1.0 | HepG2 | 48h | 12 | 244 | **99.7** |
| etoposide | 10.0 | HepG2 | 48h | 12 | 16,619 | **76.6** |
| etoposide | 100.0 | HepG2 | 48h | 12 | 46,804 | **34.0** |
| **nocodazole** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| nocodazole | 0.05 | A549 | 12h | 12 | 204 | **99.7** |
| nocodazole | 0.5 | A549 | 12h | 12 | 31,881 | **56.5** |
| nocodazole | 5.0 | A549 | 12h | 12 | 47,309 | **35.4** |
| nocodazole | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| nocodazole | 0.05 | A549 | 48h | 12 | 210 | **99.7** |
| nocodazole | 0.5 | A549 | 48h | 12 | 31,828 | **56.8** |
| nocodazole | 5.0 | A549 | 48h | 12 | 50,876 | **30.9** |
| nocodazole | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| nocodazole | 0.05 | HepG2 | 12h | 12 | 167 | **99.7** |
| nocodazole | 0.5 | HepG2 | 12h | 12 | 16,678 | **72.9** |
| nocodazole | 5.0 | HepG2 | 12h | 12 | 43,732 | **28.9** |
| nocodazole | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| nocodazole | 0.05 | HepG2 | 48h | 12 | 158 | **99.8** |
| nocodazole | 0.5 | HepG2 | 48h | 12 | 16,839 | **76.3** |
| nocodazole | 5.0 | HepG2 | 48h | 12 | 46,454 | **34.5** |
| **oligomycin** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| oligomycin | 0.1 | A549 | 12h | 12 | 240 | **99.7** |
| oligomycin | 1.0 | A549 | 12h | 12 | 15,317 | **79.1** |
| oligomycin | 10.0 | A549 | 12h | 12 | 45,636 | **37.7** |
| oligomycin | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| oligomycin | 0.1 | A549 | 48h | 12 | 235 | **99.7** |
| oligomycin | 1.0 | A549 | 48h | 12 | 16,446 | **77.7** |
| oligomycin | 10.0 | A549 | 48h | 12 | 48,206 | **34.6** |
| oligomycin | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| oligomycin | 0.1 | HepG2 | 12h | 12 | 879 | **98.6** |
| oligomycin | 1.0 | HepG2 | 12h | 12 | 29,112 | **52.7** |
| oligomycin | 10.0 | HepG2 | 12h | 12 | 44,862 | **27.1** |
| oligomycin | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| oligomycin | 0.1 | HepG2 | 48h | 12 | 916 | **98.7** |
| oligomycin | 1.0 | HepG2 | 48h | 12 | 31,992 | **54.9** |
| oligomycin | 10.0 | HepG2 | 48h | 12 | 46,815 | **34.0** |
| **paclitaxel** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| paclitaxel | 0.001 | A549 | 12h | 12 | 51 | **99.9** |
| paclitaxel | 0.01 | A549 | 12h | 12 | 32,927 | **55.1** |
| paclitaxel | 0.1 | A549 | 12h | 12 | 48,688 | **33.5** |
| paclitaxel | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| paclitaxel | 0.001 | A549 | 48h | 12 | 59 | **99.9** |
| paclitaxel | 0.01 | A549 | 48h | 12 | 34,422 | **53.3** |
| paclitaxel | 0.1 | A549 | 48h | 12 | 44,489 | **39.6** |
| paclitaxel | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| paclitaxel | 0.001 | HepG2 | 12h | 12 | 41 | **99.9** |
| paclitaxel | 0.01 | HepG2 | 12h | 12 | 15,150 | **75.4** |
| paclitaxel | 0.1 | HepG2 | 12h | 12 | 44,548 | **27.6** |
| paclitaxel | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| paclitaxel | 0.001 | HepG2 | 48h | 12 | 41 | **99.9** |
| paclitaxel | 0.01 | HepG2 | 48h | 12 | 16,569 | **76.6** |
| paclitaxel | 0.1 | HepG2 | 48h | 12 | 49,113 | **30.7** |
| **tBHQ** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| tBHQ | 3.0 | A549 | 12h | 12 | 188 | **99.7** |
| tBHQ | 30.0 | A549 | 12h | 12 | 12,419 | **83.0** |
| tBHQ | 300.0 | A549 | 12h | 12 | 44,405 | **39.4** |
| tBHQ | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| tBHQ | 3.0 | A549 | 48h | 12 | 215 | **99.7** |
| tBHQ | 30.0 | A549 | 48h | 12 | 14,182 | **80.7** |
| tBHQ | 300.0 | A549 | 48h | 12 | 41,610 | **43.5** |
| tBHQ | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| tBHQ | 3.0 | HepG2 | 12h | 12 | 923 | **98.5** |
| tBHQ | 30.0 | HepG2 | 12h | 12 | 29,823 | **51.5** |
| tBHQ | 300.0 | HepG2 | 12h | 12 | 45,471 | **26.1** |
| tBHQ | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| tBHQ | 3.0 | HepG2 | 48h | 12 | 890 | **98.7** |
| tBHQ | 30.0 | HepG2 | 48h | 12 | 32,125 | **54.7** |
| tBHQ | 300.0 | HepG2 | 48h | 12 | 46,677 | **34.2** |
| **thapsigargin** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| thapsigargin | 0.05 | A549 | 12h | 12 | 66 | **99.9** |
| thapsigargin | 0.5 | A549 | 12h | 12 | 13,818 | **81.1** |
| thapsigargin | 5.0 | A549 | 12h | 12 | 41,879 | **42.8** |
| thapsigargin | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| thapsigargin | 0.05 | A549 | 48h | 12 | 65 | **99.9** |
| thapsigargin | 0.5 | A549 | 48h | 12 | 13,638 | **81.5** |
| thapsigargin | 5.0 | A549 | 48h | 12 | 43,990 | **40.3** |
| thapsigargin | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| thapsigargin | 0.05 | HepG2 | 12h | 12 | 322 | **99.5** |
| thapsigargin | 0.5 | HepG2 | 12h | 12 | 30,850 | **49.9** |
| thapsigargin | 5.0 | HepG2 | 12h | 12 | 42,378 | **31.1** |
| thapsigargin | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| thapsigargin | 0.05 | HepG2 | 48h | 12 | 357 | **99.5** |
| thapsigargin | 0.5 | HepG2 | 48h | 12 | 33,106 | **53.3** |
| thapsigargin | 5.0 | HepG2 | 48h | 12 | 42,848 | **39.6** |
| **tunicamycin** | 0.0 | A549 | 12h | 12 | 0 | **100.0** |
| tunicamycin | 0.1 | A549 | 12h | 12 | 235 | **99.7** |
| tunicamycin | 1.0 | A549 | 12h | 12 | 15,495 | **78.9** |
| tunicamycin | 10.0 | A549 | 12h | 12 | 46,826 | **36.1** |
| tunicamycin | 0.0 | A549 | 48h | 12 | 0 | **100.0** |
| tunicamycin | 0.1 | A549 | 48h | 12 | 236 | **99.7** |
| tunicamycin | 1.0 | A549 | 48h | 12 | 15,607 | **78.8** |
| tunicamycin | 10.0 | A549 | 48h | 12 | 44,506 | **39.6** |
| tunicamycin | 0.0 | HepG2 | 12h | 12 | 0 | **100.0** |
| tunicamycin | 0.1 | HepG2 | 12h | 12 | 936 | **98.5** |
| tunicamycin | 1.0 | HepG2 | 12h | 12 | 31,866 | **48.2** |
| tunicamycin | 10.0 | HepG2 | 12h | 12 | 42,965 | **30.2** |
| tunicamycin | 0.0 | HepG2 | 48h | 12 | 0 | **100.0** |
| tunicamycin | 0.1 | HepG2 | 48h | 12 | 981 | **98.6** |
| tunicamycin | 1.0 | HepG2 | 48h | 12 | 31,377 | **55.8** |
| tunicamycin | 10.0 | HepG2 | 48h | 12 | 44,519 | **37.2** |

---

## Key Findings

### Cell-Line-Specific Sensitivity (12h timepoint)

| Stress Type | Compound | A549 Viability @ Mid Dose | HepG2 Viability @ Mid Dose | Differential |
|-------------|----------|---------------------------|----------------------------|--------------|
| **Mitochondrial** | CCCP (5 ÂµM) | 79.3% | 48.8% | **30.5% more sensitive** (HepG2) |
| **Mitochondrial** | Oligomycin (1 ÂµM) | 79.1% | 52.7% | **26.4% more sensitive** (HepG2) |
| **Oxidative** | tBHQ (30 ÂµM) | 83.0% | 51.5% | **31.5% more resistant** (A549) |
| **ER Stress** | Tunicamycin (1 ÂµM) | 78.9% | 48.2% | **30.7% more sensitive** (HepG2) |
| **ER Stress** | Thapsigargin (0.5 ÂµM) | 81.1% | 49.9% | **31.2% more sensitive** (HepG2) |
| **Microtubule** | Paclitaxel (0.01 ÂµM) | 55.1% | 75.4% | **20.3% more sensitive** (A549) |
| **Peroxide** | H2O2 (100 ÂµM) | 58.9% | 76.1% | **17.2% more resistant** (HepG2) |

### Biological Model Validation âœ…

1. **OXPHOS-dependent HepG2** â†’ Sensitive to CCCP, oligomycin (mitochondrial poisons)
2. **NRF2-primed A549** â†’ Resistant to tBHQ (oxidative stress)
3. **High ER load HepG2** â†’ Sensitive to tunicamycin, thapsigargin (ER stress)
4. **Faster-cycling A549** â†’ Sensitive to paclitaxel, nocodazole (microtubule drugs)
5. **HepG2 peroxide detox** â†’ Resistant to H2O2 (peroxide)

All predicted sensitivities match biological expectations! ðŸŽ‰
